Trump Administration Moves to Establish Regulated Marketplace for Peptides
Health Secretary Robert F. Kennedy Jr. announces plans for a regulated peptide marketplace, aiming to curb reliance on gray market imports.
POLICY WIRE — Washington, USA — U.S. Health Secretary Robert F. Kennedy Jr. announced on Tuesday that the Trump administration is working to establish a regulated marketplace for peptides. These substances, which consist of short chains of amino acids, have gained significant popularity among wellness influencers and within the Make America Healthy Again movement.
The initiative seeks to provide consumers with safer access to these products, which currently lack broad regulatory approval for safety and efficacy. Kennedy stated during a Fox News interview that the administration intends to expand access to these drugs to address the growing trend of Americans purchasing gray market peptides manufactured in China and other foreign nations.
According to a government website posting from Thursday, the Department of Health and Human Services has submitted an interim access policy regarding peptides to the White House for formal review. The proposal aims to permit specialty pharmacies to produce specific peptides, a move that has already drawn praise from various Kennedy allies involved in the supplement and peptide industry.
This policy shift follows Kennedy’s previous assertions that the FDA’s regulatory stance on wellness products would be overhauled. The FDA has historically categorized substances like BPC-157 and over a dozen other injectable peptides as restricted, placing them on lists that limit their distribution.
Reporting by Policy-Wire (PW)
